Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,382 | 582 | 99.8% |
| Education | $20.80 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,562 | 177 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,699 | 89 | $0 (2024) |
| Janssen Biotech, Inc. | $1,043 | 54 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $545.22 | 31 | $0 (2023) |
| Merck Sharp & Dohme LLC | $307.19 | 15 | $0 (2024) |
| Celgene Corporation | $301.52 | 17 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $277.67 | 14 | $0 (2017) |
| Allergan Inc. | $270.19 | 23 | $0 (2019) |
| Intercept Pharmaceuticals, Inc. | $248.37 | 13 | $0 (2024) |
| QOL Medical, LLC | $243.67 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,168 | 87 | ABBVIE INC. ($851.84) |
| 2023 | $1,308 | 59 | ABBVIE INC. ($426.11) |
| 2022 | $1,473 | 68 | ABBVIE INC. ($628.65) |
| 2021 | $1,593 | 88 | AbbVie Inc. ($507.57) |
| 2020 | $562.27 | 28 | AbbVie Inc. ($96.91) |
| 2019 | $904.06 | 51 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($196.94) |
| 2018 | $1,538 | 89 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($301.17) |
| 2017 | $1,858 | 116 | AbbVie, Inc. ($653.35) |
All Payment Transactions
586 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Immunology | ||||||
| 12/06/2024 | CapsoVision, Inc. | CapsoCam Plus (Device) | Food and Beverage | Cash or cash equivalent | $23.46 | General |
| Category: Gastroenterology | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $32.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.52 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.08 | General |
| Category: GI | ||||||
| 11/04/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug), SUTAB | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: GI COLON PREP | ||||||
| 11/04/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: Immunology | ||||||
| 10/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Immunology | ||||||
| 10/08/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: GI | ||||||
| 10/08/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/07/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/01/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,112 | 1,407 | $966,596 | $156,113 |
| 2022 | 15 | 1,017 | 1,332 | $897,343 | $145,561 |
| 2021 | 15 | 937 | 1,237 | $815,525 | $133,805 |
| 2020 | 17 | 951 | 1,259 | $762,530 | $121,458 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 303 | 445 | $275,455 | $46,317 | 16.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 144 | 144 | $134,496 | $16,027 | 11.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 72 | 72 | $84,960 | $14,675 | 17.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 91 | 192 | $71,232 | $12,822 | 18.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 147 | 157 | $101,422 | $12,314 | 12.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 72 | 72 | $57,672 | $9,398 | 16.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 82 | $45,756 | $8,092 | 17.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 54 | $46,656 | $7,948 | 17.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 62 | 62 | $37,758 | $6,655 | 17.6% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 19 | 19 | $29,317 | $5,656 | 19.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 27 | 27 | $23,220 | $5,304 | 22.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 18 | 18 | $15,462 | $3,532 | 22.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $18,970 | $3,007 | 15.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $13,024 | $2,379 | 18.3% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $11,196 | $1,986 | 17.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 270 | 428 | $266,216 | $44,924 | 16.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 145 | 145 | $137,315 | $17,339 | 12.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 62 | 138 | $66,102 | $12,120 | 18.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 51 | 51 | $61,302 | $10,412 | 17.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 60 | 70 | $61,110 | $10,307 | 16.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $58,765 | $10,130 | 17.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 120 | 132 | $86,460 | $10,070 | 11.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 70 | 125 | $41,625 | $7,340 | 17.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 29 | 29 | $25,317 | $5,681 | 22.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 25 | $23,150 | $4,234 | 18.3% |
About Dr. Lenna Martyak, M.D
Dr. Lenna Martyak, M.D is a Gastroenterology healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1164638177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lenna Martyak, M.D has received a total of $11,403 in payments from pharmaceutical and medical device companies, with $2,168 received in 2024. These payments were reported across 586 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($11,382).
As a Medicare-enrolled provider, Martyak has provided services to 4,017 Medicare beneficiaries, totaling 5,235 services with total Medicare billing of $556,936. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Santa Monica, CA
- Active Since 05/15/2007
- Last Updated 09/14/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164638177
Products in Payments
- XIFAXAN (Drug) $1,377
- STELARA (Biological) $866.10
- LINZESS (Drug) $790.96
- SKYRIZI (Biological) $569.09
- Humira (Biological) $429.12
- CREON (Drug) $423.92
- HUMIRA (Biological) $394.01
- RINVOQ (Biological) $389.12
- ZEPOSIA (Drug) $301.52
- Creon (Drug) $269.98
- DIFICID (Drug) $266.28
- OCALIVA (Drug) $248.37
- TRULANCE (Drug) $239.58
- VIBERZI (Drug) $239.48
- DUPIXENT (Biological) $236.89
- Entyvio (Biological) $226.44
- ENTYVIO (Biological) $209.30
- Alinia Tablets 500mg 30 count bottle (Drug) $166.90
- ZENPEP (Drug) $161.24
- PLENVU (Drug) $159.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Santa Monica
Alireza Sedarat, Md, MD
Gastroenterology — Payments: $104,838
Marc Wishingrad, Md, MD
Gastroenterology — Payments: $24,677
Dr. Rudolph Bedford, M.d, M.D
Gastroenterology — Payments: $17,303
Dr. Kamyar Shahedi, M.d, M.D
Gastroenterology — Payments: $8,847
Claudia Sanmiguel, M.d, M.D
Gastroenterology — Payments: $6,321
Charles Frankel, M.d, M.D
Gastroenterology — Payments: $4,737